4
Changes in Ownership
Obsidian Therapeutics, Inc. Filed Acc 0001193125-26-460934
Options or other derivatives
- Chief Financial Officer acquired 164,790 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Feder Julie B · Chief Financial Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-08-03 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +164,790 | 164,790 | D |
Loading xslF345X06/ownership.xml…